Form 4: Molina Healthcare Director Receives Routine Equity Compensation Grant

Molina Healthcare, Inc. Director Dale B. Wolf was granted 180 shares of common stock valued at $306.29 per share as part of his scheduled compensation for services.

Summary

• Dale B. Wolf, a Director of Molina Healthcare, Inc. (MOH), acquired 180 shares of common stock on July 1, 2025.
• The shares were granted under the Issuer's 2025 Equity Incentive Plan as compensation for his services as a Director.
• This grant is part of an annual equity award totaling $220,000 for each director, with $55,000 granted quarterly.
• The number of shares granted (180) was determined by the closing price of Molina Healthcare's common stock on July 1, 2025, which was $306.29 per share.
• Following this transaction, Dale B. Wolf beneficially owns 14,389 shares, which are held indirectly by the Dale B. Wolf Revocable Trust.

Sentiment

Score: 6

Explanation: The document reports a routine, pre-planned equity grant to a director as part of compensation. This is a neutral to slightly positive event as it aligns director interests with shareholders, but it does not indicate any significant new positive or negative developments for the company.

Positives

• Director compensation through equity grants aligns the interests of the director with those of the shareholders, promoting long-term value creation.
• The grant is part of a pre-defined 2025 Equity Incentive Plan, indicating a structured and transparent compensation framework.

Future Outlook

The filing details a specific equity grant as part of a pre-existing compensation plan for directors, but does not provide broader forward-looking statements or guidance on company performance or strategy.

Management Comments

• The grant of stock was made under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
• The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter.
• The number of shares granted was determined by the closing price of the Issuer's common stock on the grant date.

Industry Context

This Form 4 filing is a routine disclosure of insider stock ownership changes, specifically a compensation grant to a director. Such equity grants are a common practice across industries, particularly in healthcare, to align the interests of directors with those of shareholders and to incentivize long-term performance. It does not provide specific industry-wide trends or competitive analysis.

Comparison to Industry Standards

• Equity compensation for directors is a standard practice in publicly traded companies, including those in the healthcare sector, to attract and retain qualified board members.
• The structure of granting a fixed dollar value of equity quarterly, based on the stock's closing price, is a common method for administering such awards, similar to practices observed in companies like UnitedHealth Group or Elevance Health for their non-employee directors.
• The specific value of the annual equity award ($220,000) would need to be benchmarked against peer companies within the managed care or healthcare services industry to assess its competitiveness, but the filing itself does not provide such comparative data.

Corporate Governance

Related Party Transactions

• The shares are held by Dale B. Wolf Revocable Trust, of which Dale B. Wolf is the sole trustee, indicating an indirect beneficial ownership structure.

Stakeholder Impact

• Shareholders: Director's equity ownership aligns interests with shareholders, potentially fostering long-term value creation.

Next Steps

• Future quarterly equity grants to directors as per the 2025 Equity Incentive Plan.

Key Dates

Keywords

Molina Healthcare, MOH, Form 4, SEC filing, insider transaction, equity grant, director compensation, stock award, beneficial ownership, Dale B. Wolf